https://kstockbriefing.com
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace announced it will hold an Investor Relations (IR) conference via conference call and webcasting on October 31, 2024, at 15:00 to present its Q3 2024 financial results. 📊 [Key Disclosure Details & Summary of Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Reviewing Published…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace announced it will hold an Investor Relations (IR) conference from November 1 to November 6, 2024, to present its Q3 2024 business performance and future outlook to domestic institutional investors. 📊 [Key Disclosure Details & Summary of Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint)…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This filing discloses an amendment to Hanwha Ocean’s loan decision for its Singaporean subsidiary to finance a tender offer for a Singaporean shipyard, increasing the loan amount from approximately KRW 209.8B to KRW 234.2B. 📊 [Key Disclosure Highlights & Summary] [Detailed Loan Terms] [Other Material Notes]…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This filing discloses an amendment to Hanwha Ocean’s planned sale of its entire 241.4M share stake in Singaporean offshore structure manufacturer Dyna-Mac to its affiliate SG Holdings, revising the disposal amount upward from KRW 149.3B to KRW 166.7B. 📊 [Key Disclosure Highlights & Summary] [Detailed Terms…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace updated its disclosure to increase its loan amount to its Singapore subsidiary (Hanwha Ocean SG Holdings) from approximately KRW 569.9B to KRW 636.3B to support the tender offer for Dyna-Mac. 📊 [Key Disclosure Details & Summary of Figures] Key Corrections (Before Correction → After…
![[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in Europe (Part 1 & 2) / 2024-10-14](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환셀트리온.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion announced that it has submitted an application for the Phase 3 clinical trial plan (Part 1 & 2) of CT-P55, a biosimilar to the plaque psoriasis treatment Cosentyx, to the European Medicines Agency (EMA). 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment (Key…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace updated its disclosure as the estimated acquisition amount for the tender offer of Dyna-Mac Holdings by its Singapore subsidiary (Hanwha Ocean SG Holdings) was increased from approximately KRW 779.7B to KRW 870.5B. 📊 [Key Disclosure Details & Summary of Figures] Key Corrections (Before Correction…
![[Disclosure] ISU PETASYS (007660) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2024-10-14](https://kstockbriefing.com/wp-content/uploads/2026/05/포맷변환이수페타시스.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ISU PETASYS has decided to invest approx. KRW 3.52B (85% stake) in cash to establish a new joint venture (ISU-APEX) in Thailand for a strategic alliance with a foreign entity. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Establishment of…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ISU PETASYS has decided to invest approx. KRW 3.52B (85% stake) to establish a new joint venture (ISU-APEX) in Thailand for a strategic alliance, correcting a clerical error regarding the ratio to total equity. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up…
![[Disclosure] Samsung Electro-Mechanics (009150) – Advance Notice of Earnings Release / 2024-10-10](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환삼성전기-2.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Electro-Mechanics provided advance notice that it plans to release its provisional Q3 2024 (July–September) earnings on October 29, 2024. 📊 [Summary of Key Disclosure Facts & Figures] 1. Basic Information 2. Period Covered 3. Expected Disclosure Schedule 4. Other Key Investment Notes 📝 Editor’s Comment…